Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes
about
Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical SynthesisDevelopment of a minimal saponin vaccine adjuvant based on QS-21Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresolIdentification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.Synthesis of QS-21-based immunoadjuvants.An overview of adjuvant formulations and delivery systems."Pruning of biomolecules and natural products (PBNP)": an innovative paradigm in drug discovery.Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.Carbohydrate-based vaccine adjuvants - discovery and development.Quillaja Saponin Variants with Central Glycosidic Linkage Modifications Exhibit Distinct Conformations and Adjuvant ActivitiesVersatile strategy for the divergent synthesis of linear oligosaccharide domain variants of Quillaja saponin vaccine adjuvants.Chemistry and biology of oligovalent β-(1→2)-linked oligomannosides: new insights into carbohydrate-based adjuvants in immunotherapy.Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.Rapid assembly of the doubly-branched pentasaccharide domain of the immunoadjuvant jujuboside A via convergent B(C6F5)3-catalyzed glycosylation of sterically-hindered precursors.
P2860
Q28829361-8B3584E4-A0B6-41E8-A098-20474E2B2921Q34433407-5AE2B7E6-B998-475B-AFEA-926CB90A5711Q35539051-778A18CC-5A4D-4449-A83A-95334D4E5754Q36466129-9CB613B5-8A3C-4F81-9085-395419C75855Q37076109-08F24575-D6D2-4D49-AFB3-BE3FD7BFCB49Q37608887-E1C32DDE-68B4-4BCC-B92E-8B368DC55F8DQ38126953-E16779CC-30BE-4487-AD20-DAC4482EC92CQ38475630-85D2E9D9-1294-4B39-B121-5833F77A7170Q38533442-E2DBDA5C-8575-4915-B921-2D9D1340DC69Q38587300-5ABAFB1A-D45F-4BBE-A887-91EE5CF22DADQ39236688-9331AFE6-A25E-48C3-B1BD-6DAC711FAC72Q43178410-33BB6A68-1DCC-41E1-8E27-4BF1417B67F5Q43635984-B9D1DCEF-CC10-47B7-9D3D-179B3AD7D28EQ49620985-AA22EDE4-74EE-4147-822D-910FFB749648Q52652417-681A23C1-D6E6-4F74-81E6-AC757337A977
P2860
Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Synthesis and preclinical eval ...... juvants and mechanistic probes
@ast
Synthesis and preclinical eval ...... juvants and mechanistic probes
@en
type
label
Synthesis and preclinical eval ...... juvants and mechanistic probes
@ast
Synthesis and preclinical eval ...... juvants and mechanistic probes
@en
prefLabel
Synthesis and preclinical eval ...... juvants and mechanistic probes
@ast
Synthesis and preclinical eval ...... juvants and mechanistic probes
@en
P2093
P2860
P356
P1476
Synthesis and preclinical eval ...... juvants and mechanistic probes
@en
P2093
David Y Gin
Eric K Chea
Govind Ragupathi
Jeffrey R Gardner
Michelle M Adams
Payal Damani
Philip O Livingston
P2860
P304
13448-13457
P356
10.1021/JA305121Q
P407
P577
2012-08-06T00:00:00Z